Windtree Therapeutics Files 8-K on Security Holder Rights
Ticker: WINTW · Form: 8-K · Filed: Feb 18, 2025 · CIK: 946486
| Field | Detail |
|---|---|
| Company | Windtree Therapeutics Inc /De/ (WINTW) |
| Form Type | 8-K |
| Filed Date | Feb 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
Related Tickers: WINT
TL;DR
WINT filed an 8-K: changes to security holder rights & bylaws. Check for impact.
AI Summary
On February 14, 2025, Windtree Therapeutics, Inc. filed an 8-K report detailing material modifications to security holder rights and amendments to its articles of incorporation or bylaws. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company, formerly known as Discovery Laboratories Inc., is incorporated in Delaware and operates in the biological products sector.
Why It Matters
This filing indicates potential changes affecting the rights of Windtree Therapeutics' security holders and updates to the company's foundational documents, which could impact investors.
Risk Assessment
Risk Level: medium — Filings concerning modifications to security holder rights and corporate bylaws can introduce uncertainty and potential shifts in shareholder power or value.
Key Players & Entities
- Windtree Therapeutics, Inc. (company) — Registrant
- Discovery Laboratories Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- February 14, 2025 (date) — Date of earliest event reported
FAQ
What specific material modifications were made to the rights of security holders?
The filing indicates material modifications to the rights of security holders were made, but the specific details are not provided in this summary of the 8-K.
What are the key amendments to the Articles of Incorporation or Bylaws?
The 8-K report states there were amendments to the Articles of Incorporation or Bylaws, but the exact nature of these amendments is not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 14, 2025.
What is Windtree Therapeutics, Inc.'s Standard Industrial Classification (SIC) code?
Windtree Therapeutics, Inc.'s SIC code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What were Windtree Therapeutics, Inc.'s former company names?
Windtree Therapeutics, Inc. was formerly known as Discovery Laboratories Inc. /DE/, Ansan Pharmaceuticals Inc., and Ansan Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 18, 2025 regarding WINDTREE THERAPEUTICS INC /DE/ (WINTW).